ATE310083T1 - Deprenyl induziertes protein - Google Patents
Deprenyl induziertes proteinInfo
- Publication number
- ATE310083T1 ATE310083T1 AT96944634T AT96944634T ATE310083T1 AT E310083 T1 ATE310083 T1 AT E310083T1 AT 96944634 T AT96944634 T AT 96944634T AT 96944634 T AT96944634 T AT 96944634T AT E310083 T1 ATE310083 T1 AT E310083T1
- Authority
- AT
- Austria
- Prior art keywords
- deprenyl
- induced protein
- polypeptide
- dip
- induces
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
- C07C211/23—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton the carbon skeleton containing carbon-to-carbon triple bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/31—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by at least three rings
- C07C211/32—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by at least three rings containing dibenzocycloheptane or dibenzocycloheptene ring systems or condensed derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D313/14—[b,f]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/30—Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
- C07C2603/32—Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9600660.6A GB9600660D0 (en) | 1996-01-12 | 1996-01-12 | Protein |
PCT/EP1996/005800 WO1997025421A2 (en) | 1996-01-12 | 1996-12-21 | PROTEIN INDUCED BY DEPRENYL$m(3) |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE310083T1 true ATE310083T1 (de) | 2005-12-15 |
Family
ID=10786972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96944634T ATE310083T1 (de) | 1996-01-12 | 1996-12-21 | Deprenyl induziertes protein |
Country Status (8)
Country | Link |
---|---|
US (1) | US6232118B1 (de) |
EP (1) | EP0873406B1 (de) |
JP (1) | JP2000504211A (de) |
AT (1) | ATE310083T1 (de) |
AU (1) | AU1305097A (de) |
DE (1) | DE69635457D1 (de) |
GB (1) | GB9600660D0 (de) |
WO (1) | WO1997025421A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000021513A2 (en) * | 1998-10-09 | 2000-04-20 | Shankar L Sai Latha | Methods for treating multiple sclerosis |
EP1621190A1 (de) * | 1998-10-09 | 2006-02-01 | L. Sai Latha Shankar | Deprenylderivate zur Behandlung von Multipler Sklerose |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
US5646008A (en) | 1993-06-22 | 1997-07-08 | The Regent Of The University Of Michigan | Vertebrate apoptosis gene: compositions and methods |
-
1996
- 1996-01-12 GB GBGB9600660.6A patent/GB9600660D0/en active Pending
- 1996-12-21 AU AU13050/97A patent/AU1305097A/en not_active Abandoned
- 1996-12-21 DE DE69635457T patent/DE69635457D1/de not_active Expired - Fee Related
- 1996-12-21 EP EP96944634A patent/EP0873406B1/de not_active Expired - Lifetime
- 1996-12-21 AT AT96944634T patent/ATE310083T1/de not_active IP Right Cessation
- 1996-12-21 US US09/101,519 patent/US6232118B1/en not_active Expired - Lifetime
- 1996-12-21 JP JP9524806A patent/JP2000504211A/ja not_active Ceased
- 1996-12-21 WO PCT/EP1996/005800 patent/WO1997025421A2/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
GB9600660D0 (en) | 1996-03-13 |
JP2000504211A (ja) | 2000-04-11 |
EP0873406A2 (de) | 1998-10-28 |
DE69635457D1 (de) | 2005-12-22 |
EP0873406B1 (de) | 2005-11-16 |
AU1305097A (en) | 1997-08-01 |
US6232118B1 (en) | 2001-05-15 |
WO1997025421A3 (en) | 1997-09-12 |
WO1997025421A2 (en) | 1997-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ330897A (en) | Human trk receptors and neurotropic factor inhibitors | |
IT8619338A0 (it) | Peptide sintetico ad attivita'interleukina 1 umana. | |
MX9606492A (es) | Secuencias peptidicas, guias, sinteticas. | |
DE3789413T2 (de) | Lymphokin-ähnliche Peptide. | |
ES2107033T3 (es) | Peptidos bpc, su preparacion y su utilizacion. | |
HK1017692A1 (en) | Endothelial cell proliferation inhibitor and method of use | |
DE59810198D1 (de) | Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung | |
ES2058479T3 (es) | Compuestos peptidicos. | |
RU93005126A (ru) | Гелонин, днк | |
DE69635457D1 (de) | Deprenyl induziertes protein | |
DE68922888D1 (de) | Verwendung eines kationischen Oberflächenaktivmittels zur Extraktion des Hauptprotein-Antigens der äusseren Membran von Chlamydia. | |
EP1238058A4 (de) | Verwendung von colostrinin, seine peptidbestandteile und ihre analoge zur förderung der neuronalen zelldifferenzierung | |
DE3869939D1 (de) | Biologisch wirksame peptide. | |
DE69534738D1 (de) | Leukocyten-aktivierender Faktor | |
IT8620026A0 (it) | Tripeptide ad attivita'immunostimolante. | |
DE69733026D1 (de) | Cyclin e spezifische konstrukte und komplexe | |
IT8620027A0 (it) | Tripeptide ad attivita'immunostimolante. | |
DE3780388D1 (de) | Fsh-stimulierendes peptid. | |
DE3782199T2 (de) | Biologisch aktive peptide tan-866. | |
ES2114170T3 (es) | Peptidos con actividad organo-protectora, su procedimiento de preparacion y su utilizacion en la terapia. | |
DE60138885D1 (de) | Polypeptide mit aktivität der stimulierung von neutrophilen | |
ATE81531T1 (de) | Biologisch aktive peptide tan-866. | |
ATE96806T1 (de) | Peptide mit laminin-wirksamkeit. | |
ATE103339T1 (de) | Lymphokin-aehnliche peptide. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |